Vis enkel innførsel

dc.contributor.authorNakalega, Rita
dc.contributor.authorMukiza, Nelson
dc.contributor.authorMenge, Robert
dc.contributor.authorKizito, Samuel
dc.contributor.authorBabirye, Juliet Allen
dc.contributor.authorKuteesa, Cynthia Ndikuno
dc.contributor.authorMawanda, Denis
dc.contributor.authorMulumba, Emmie
dc.contributor.authorNabukeera, Josephine
dc.contributor.authorGgita, Joseph
dc.contributor.authorNakanjako, Lydia
dc.contributor.authorAkello, Carolyne
dc.contributor.authorMirembe, Brenda Gati
dc.contributor.authorLukyamuzi, Zubair
dc.contributor.authorNakaye, Catherine
dc.contributor.authorKataike, Hajira
dc.contributor.authorMaena, Joel
dc.contributor.authorEtima, Juliane
dc.contributor.authorNabunya, Hadijah Kalule
dc.contributor.authorBiira, Florence
dc.contributor.authorNagawa, Christine
dc.contributor.authorHeffron, Renee
dc.contributor.authorCelum, Connie
dc.contributor.authorGandhi, Monica
dc.contributor.authorMujugira, Andrew
dc.date.accessioned2024-02-20T11:53:37Z
dc.date.available2024-02-20T11:53:37Z
dc.date.created2023-06-30T13:20:35Z
dc.date.issued2023
dc.identifier.citationNakalega, R., Mukiza, N., Menge, R., Kizito, S., Babirye, J. A., Kuteesa, C. N., ... & Mujugira, A. (2023). Feasibility and acceptability of peer-delivered HIV self-testing and PrEP for young women in Kampala, Uganda. BMC Public Health, 23(1), 1163.en_US
dc.identifier.issn1471-2458
dc.identifier.urihttps://hdl.handle.net/11250/3118649
dc.description.abstractBackground Adolescent girls and young women (AGYW) account for 29% of new HIV infections in Uganda despite representing just 10% of the population. Peer support improves AGYW linkage to HIV care and medication adherence. We evaluated the feasibility and acceptability of peer delivered HIV self-tests (HIVST) and oral pre-exposure prophylaxis (PrEP) to young women in Uganda. Methods Between March and September 2021, we conducted a pilot study of 30 randomly selected young women, aged 18–24 years, who had received oral PrEP for at least three months, but had suboptimal adherence as measured by urine tenofovir testing (<1500 ng/ml). Participants were ofered daily oral PrEP and attended clinic visits three and six months after enrollment. Between clinic visits, participants were visited monthly by trained peers who delivered HIVST and PrEP. Feasibility and acceptability of peer-delivered PrEP and HIVST (intervention) were measured by comparing actual versus planned intervention delivery and product use. We conducted two focus groups with young women, and fve in-depth interviews with peers and health workers to explore their experiences with intervention delivery. Qualitative data were analyzed using thematic analysis. Results At baseline, all 30 enrolled young women (median age 20 years) accepted peer-delivered PrEP and HIVST. Peer delivery visit completion was 97% (29/30) and 93% (28/30) at three and six months, respectively. The proportion of participants with detectable tenofovir in urine was 93% (27/29) and 57% (16/28) at months three and six, respectively. Four broad themes emerged from the qualitative data: (1) Positive experiences of peer delivered HIVST and PrEP; (2) The motivating efect of peer support; (3) Perceptions of female controlled HIVST and PrEP; and (4) Multi-level barriers to HIVST and PrEP use. Overall, peer delivery motivated young women to use HIVST and PrEP and encouraged persistence on PrEP by providing non-judgmental client-friendly services and adherence support. Conclusion Peer delivery of HIVST and oral PrEP was feasible and acceptable to this sample of young women with suboptimal PrEP adherence in Uganda. Future larger controlled studies should evaluate its efectiveness among African AGWY.en_US
dc.language.isoengen_US
dc.publisherBMCen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleFeasibility and acceptability of peer-delivered HIV self-testing and PrEP for young women in Kampala, Ugandaen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holderThe authorsen_US
dc.subject.nsiVDP::Medisinske Fag: 700en_US
dc.source.volume23en_US
dc.source.journalBMC Public Healthen_US
dc.identifier.doi10.1186/s12889-023-16081-0
dc.identifier.cristin2159890
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal